Determine the necessary mass, volume, or concentration for preparing a solution.
This is a demo store. No orders will be fulfilled.
| SKU | Size | Availability |
Price | Qty |
|---|---|---|---|---|
|
Ab209922-100μg
|
100μg |
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
|
$109.90
|
|
|
Ab209922-1mg
|
1mg |
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
|
$509.90
|
|
|
Ab209922-5mg
|
5mg |
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
|
$1,399.90
|
|
|
Ab209922-10mg
|
10mg |
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
|
$2,299.90
|
|
Purity≥95% (SDS-PAGE&SEC-HPLC); Endotoxin Level<1.0 EU/mg; Human IgG1; CHO; ELISA, Flow Cytometry, Functional assay, Animal Model; Unconjugated
| Product Name | Merck anti-Amyloid beta 19.3 (anti-Amyloid Beta) - Primary antibody, specific to APP, Human IgG1 |
|---|---|
| Synonyms | A4_HUMAN antibody | AAA antibody | ABETA antibody | ABPP antibody | AD1 antibody | Anti-Amyloid Beta | alpha-sAPP | AICD-50 antibody | AICD-57 antibody | AICD-59 antibody | AID(50) antibody | AID(57) antibody | AID(59) antibody | Alzheimer disease amyloid |
| Specifications & Purity | Carrier Free, Recombinant, ExactAb™, Low Endotoxin, Azide Free, Validated, Animal Free, ≥95%(SDS-PAGE&SEC-HPLC), See COA |
| Biochemical and Physiological Mechanisms | Functions as a cell surface receptor and performs physiological functions on the surface of neurons relevant to neurite growth, neuronal adhesion and axonogenesis. Involved in cell mobility and transcription regulation through protein-protein interactions |
| Host species | Human |
| Specificity | APP |
| Conjugation | Unconjugated |
| Grade | Animal Free, Azide Free, Carrier Free, ExactAb™, Low Endotoxin, Recombinant, Validated |
| Product Description |
Merck anti-Amyloid beta 19.3 (anti-Amyloid Beta) is a human monoclonal antibody targeting beta-amyloid with the potential to treat Alzheimer’s disease. |
| Isotype | Human IgG1 |
|---|---|
| Light Chain Type | kappa |
| SDS-PAGE | 150 kDa |
| Purification Method | Protein A purified |
| Concentration | See COA |
| Storage Temp | Store at -80°C,Avoid repeated freezing and thawing |
| Shipped In | Ice chest + Ice pads |
| Stability And Storage | Store at -80℃ for 24 months. Upon receipt, it is recommended to aliquot. Avoid freeze/thaw cycle. |
| Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
|---|
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Merck anti-Amyloid beta 19.3 (anti-Amyloid Beta) (Ab209922) - ELISA
Immobilized Recombinant AB(1-42)-QY-monomer protein at 1.0 μg/mL can bind Merck anti-Amyloid beta 19.3 (anti-Amyloid Beta) (Ab209922) with the EC₅₀ of 14.44 ng/mL.
Merck anti-Amyloid beta 19.3 (anti-Amyloid Beta) (Ab209922) - SEC
The purity of Merck anti-Amyloid beta 19.3 (anti-Amyloid Beta) (Ab209922) is more than 95% verified by HPLC.
Starting at $109.90
Starting at $109.90